SEC ownership of Evogene Ltd.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001574565.

Comparable stake leader

L.I.A. Pure Capital Ltd

Disclosed value leader

L.I.A. Pure Capital Ltd

Comparable rows

15/20

Latest evidence

08 Sep 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
15 of 20
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
L.I.A. Pure Capital Ltd
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
08 Sep 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001574565
Issuer location
Rehovot, Israel

Ownership snapshot

Top shareholders of Evogene Ltd. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
L.I.A. Pure Capital Ltd
Disclosed value leader
L.I.A. Pure Capital Ltd
Comparable rows
15/20
Latest evidence
08 Sep 2026
13D/G 3/4/5 13F Lead comparable stake: 19% 5 rows are not safely comparable across share classes. 13D/G row: L.I.A. Pure Capital Ltd Showing 1-8 of 20 holder rows.

Quick read

L.I.A. Pure Capital Ltd leads the comparable SEC ownership view at 19%.

15 of 20 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens L.I.A. Pure Capital Ltd's linked filing trail.
Comparable ownership Top 5
L.I.A. Pure Capital Ltd 19%
Leon Recanati 8.6%
ARMISTICE CAPITAL, LLC 5%
HRT FINANCIAL LP 0.68%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.51%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 20 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
L.I.A. Pure Capital Ltd
13D/G
19%
$2,140,242
3,057,488 shares
$0 08 Sep 2026
Leon Recanati
3/4/5 13D/G
Director · RECANATI LEON
8.6%
from 13D/G
$646,265
1,346,386 shares
mixed-class rows
+$692,100 04 Sep 2026
ARMISTICE CAPITAL, LLC
13D/G
5%
$328,228
713,539 shares
$0 30 Jun 2026
HRT FINANCIAL LP
13F
Company
13F
0.68%
$45,000
107,198 shares
— 30 Jun 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
13F
0.51%
$33,889
80,078 shares
— 30 Jun 2026
CITADEL ADVISORS LLC
13F
Company
13F
0.32%
$21,383
50,526 shares
— 30 Jun 2026
XTX Topco Ltd
13F
Company
13F
0.12%
$8,212
19,404 shares
— 30 Jun 2026
UBS Group AG
13F
Company
13F
0.07%
$4,737
10,790 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$692,777.

Buys
$692,777
Insiders: 2
Sells
$0
Insiders: 0
Net
+$692,777
Shares: +1,261,129
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 1,261,129 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 1,260,000 0 $692,100 $0 +$692,100
3-6 1,129 0 $677 $0 +$677
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-10 of 10 reporting-owner rows connected to Evogene Ltd.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
10
Largest Forms 3/4/5 holder
Leon Recanati
Net 12M change
+$692,777
Latest report
04 Sep 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Leon Recanati Director $646,265 +$692,100 +107% Mixed 04 Sep 2026
Gabi Tarcic Chief Development Officer $25,877 +$677 +2.7% Mixed 04 Jun 2026
Nir Nimrodi Director $4,800 Mixed 04 Sep 2026
Dan Michael Falk Director $1,200 Mixed 04 Sep 2026
Adrian John Percy Director $1,200 Mixed 04 Sep 2026
Sarit Firon Director Mixed 18 Mar 2026
Ilia Zhidkov Chief Technology Officer Mixed 18 Mar 2026
Polina Ravzin VP Finance Mixed 01 Apr 2026
Yaron Eldad Chief Financial Officer Mixed 18 Mar 2026
Ofer Haviv President and CEO, Director Mixed 18 Mar 2026

Recent insider transactions for Evogene Ltd.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Leon Recanati EVGN Stock Option (right to buy) Award 2,500 2,500 04 Sep 2026 Direct
Nir Nimrodi EVGN Stock Option (right to buy) Award 10,000 10,000 04 Sep 2026 Direct
Adrian John Percy EVGN Stock Option (right to buy) Award 2,500 2,500 04 Sep 2026 Direct
Dan Michael Falk EVGN Stock Option (right to buy) Award 2,500 2,500 04 Sep 2026 Direct
Leon Recanati EVGN Ordinary Shares Purchase 52% $292,100 $0.6350 460,000 1,343,886 11 Aug 2026 Direct
Leon Recanati EVGN Ordinary Shares Purchase 953.7% $400,000 $0.5000 800,000 883,886 04 Aug 2026 Direct
Gabi Tarcic EVGN Ordinary Shares Purchase $677 $0.6000 1,129 1,129 04 Jun 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .